BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1680495)

  • 41. Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients.
    Thiele J; Kvasnicka HM; Beelen DW; Zirbes TK; Jung F; Reske D; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2000 Aug; 26(3):275-81. PubMed ID: 10967565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients.
    Thiele J; Zankovich R; Steinberg T; Fischer R; Diehl V
    Hematol Oncol; 1989; 7(5):327-43. PubMed ID: 2767619
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic Myeloid Leukemia With Myelofibrosis-Like Features. Clues of Accelerated Phase?
    Binotto G; Bertorelle R; Bonaldi L; Frison L; Vianello F; Pizzi M
    Int J Surg Pathol; 2019 Oct; 27(7):771-772. PubMed ID: 30813806
    [No Abstract]   [Full Text] [Related]  

  • 44. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic significance of the histomorphometric features of bone marrow trephine biopsies in patients with chronic myeloid leukemia.
    Lamba A; Dey P; Kumari S; Marwaha N
    Anal Quant Cytol Histol; 2007 Dec; 29(6):370-6. PubMed ID: 18225393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polyclonal hematopoiesis maintained in patients with bone marrow failure harboring a minor population of paroxysmal nocturnal hemoglobinuria-type cells.
    Ishiyama K; Chuhjo T; Wang H; Yachie A; Omine M; Nakao S
    Blood; 2003 Aug; 102(4):1211-6. PubMed ID: 12676778
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blastic phase of agnogenic myeloid metaplasia simulating malignant lymphoma.
    Cehreli C; Ezdinli EZ; Li CY; Krmpotic E
    Cancer; 1976 Sep; 38(3):1297-305. PubMed ID: 953969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [In-vitro change in CFU-GM in chronic myeloid leukemia and myelodysplastic syndromes. Its implication in the dysfunction of the hematologic barrier].
    Gronda M; Malka A; Demattei A; Elizalde P; Santarelli MT; Bianchi de Di Risio CC
    Sangre (Barc); 1988 Aug; 33(4):277-81. PubMed ID: 3187844
    [No Abstract]   [Full Text] [Related]  

  • 49. Megakaryocytes carry the fused bcr-abl gene in chronic myeloid leukaemia: a fluorescence in situ hybridization analysis from bone marrow biopsies.
    Nolte M; Werner M; Ewig M; von Wasielewski R; Link H; Diedrich H; Georgii A
    Virchows Arch; 1996 Mar; 427(6):561-5. PubMed ID: 8605566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Pathological characteristics of leukemia patients with secondary myelofibrosis and their relationship with the prognosis of disease].
    Guan JH; Wang XN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):311-4. PubMed ID: 23628022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute myelofibrosis: a report of three cases.
    Fabich DR; Raich PC
    Am J Clin Pathol; 1977 Apr; 67(4):334-8. PubMed ID: 851094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progressive myelofibrosis in agnogenic myeloid metaplasia.
    Lohmann TP; Beckman EN
    Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J; Simon KG; Fischer R; Zankovich R
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Current perspective in agnogenic myeloid metaplasia.
    Tefferi A; Silverstein MN
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():169-71. PubMed ID: 8951788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic myelogenous leukemia: molecular and cellular aspects.
    Pasternak G; Hochhaus A; Schultheis B; Hehlmann R
    J Cancer Res Clin Oncol; 1998; 124(12):643-60. PubMed ID: 9879825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Splenic hematopoiesis in polycythemia vera. A morphologic and immunohistologic study.
    Wolf BC; Banks PM; Mann RB; Neiman RS
    Am J Clin Pathol; 1988 Jan; 89(1):69-75. PubMed ID: 3276145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential diagnosis of massive splenomegaly. Agnogenic myeloid metaplasia versus chronic granulocytic leukemia.
    LINMAN JW
    Med Clin North Am; 1962 Jan; 46():49-62. PubMed ID: 14465617
    [No Abstract]   [Full Text] [Related]  

  • 58. Prognostic evaluation of initial bone marrow histopathological features in chronic granulocytic leukemia.
    Cervantes F; Rozman C; Feliu E
    Acta Haematol; 1989; 82(1):12-5. PubMed ID: 2505469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Zirbes TK; Birnbaum F; Kressmann C; Melguizo-Grahmann M; Frackenpohl H; Sprungmann C; Leder LD; Diehl V; Zankovich R; Schaefer HE; Niederle N; Fischer R
    Leuk Lymphoma; 2000 Jan; 36(3-4):295-308. PubMed ID: 10674901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical conference: Modes of blast transformation in chronic myeloid leukemia].
    Audebert AA; Zittoun R; Cadiou M; Bousser J
    Nouv Rev Fr Hematol; 1975; 15(2):270-8. PubMed ID: 126437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.